Article
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
10 Dec 1998
Abstract excerpt
Standard protocols for the generation of adenoassociated virus type 2 (AAV-2)-based vectors for human gene therapy applications require cotransfection of cells with a recombinant AAV (rAAV) vector plasmid and a packaging plasmid that provides the AAV rep and cap genes. The transfected cells must also be overinfected with a helper virus, e.g., adenovirus (Ad), which delivers multiple helper functions necessary for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
